SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17962206
Source:
http://linkedlifedata.com/resource/pubmed/id/17962206
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021760
,
umls-concept:C0041365
,
umls-concept:C0175630
,
umls-concept:C2239176
pubmed:issue
2
pubmed:dateCreated
2008-2-4
pubmed:abstractText
A large amount of evidence suggests a possible role of interleukin-6 (IL-6) in the pathogenesis of hepatocellular carcinoma (HCC).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17962206-18522933
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1569-8041
pubmed:author
pubmed-author:BonciminoAA
,
pubmed-author:CorazzaG RGR
,
pubmed-author:De AmiciMM
,
pubmed-author:MorattiRR
,
pubmed-author:PaglinoCC
,
pubmed-author:PortaCC
,
pubmed-author:QuagliniSS
,
pubmed-author:TaglianiFF
pubmed:issnType
Electronic
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
353-8
pubmed:dateRevised
2008-9-2
pubmed:meshHeading
pubmed-meshheading:17962206-Aged
,
pubmed-meshheading:17962206-Carcinoma, Hepatocellular
,
pubmed-meshheading:17962206-Case-Control Studies
,
pubmed-meshheading:17962206-Disease-Free Survival
,
pubmed-meshheading:17962206-Female
,
pubmed-meshheading:17962206-Follow-Up Studies
,
pubmed-meshheading:17962206-Hepatitis C, Chronic
,
pubmed-meshheading:17962206-Humans
,
pubmed-meshheading:17962206-Interleukin-6
,
pubmed-meshheading:17962206-Liver Cirrhosis
,
pubmed-meshheading:17962206-Liver Neoplasms
,
pubmed-meshheading:17962206-Male
,
pubmed-meshheading:17962206-Middle Aged
,
pubmed-meshheading:17962206-Neoplasm Staging
,
pubmed-meshheading:17962206-Probability
,
pubmed-meshheading:17962206-ROC Curve
,
pubmed-meshheading:17962206-Reference Values
,
pubmed-meshheading:17962206-Risk Assessment
,
pubmed-meshheading:17962206-Sensitivity and Specificity
,
pubmed-meshheading:17962206-Statistics, Nonparametric
,
pubmed-meshheading:17962206-Survival Analysis
,
pubmed-meshheading:17962206-Tumor Markers, Biological
,
pubmed-meshheading:17962206-alpha-Fetoproteins
pubmed:year
2008
pubmed:articleTitle
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.
pubmed:affiliation
Internal Medicine and Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia, Italy. c.porta@smatteo.pv.it
pubmed:publicationType
Journal Article
,
Comparative Study